Panelists discuss how adverse events associated with conventional therapies for alopecia areata (AA) are monitored through regular patient assessments, and how these events are managed by adjusting ...
Christopher Sayed, MD, discusses how hidradenitis suppurativa typically presents and looks forward, following the November approval of bimekizumab.
New data suggest venetoclax may offset the negative prognostic impact of short telomeres in patients with chronic lymphocytic ...
Researchers identified a 15-year shift toward surgical de-escalation in gynecologic oncology, marked by fewer surgical ...
Analyzing patients' travel time to receive emergency surgical services provides valuable insights that can inform policy ...
Waist circumference and waist-to-hip ratio show stronger links to colorectal cancer (CRC) than body mass index (BMI), a new ...
Infection risk remains a prominent clinical concern for patients with multiple myeloma (MM), even with the advent of modern, ...
Esketamine (Spravato; Johnson & Johnson) is now the first and only monotherapy for adults with major depressive disorder (MDD ...
Joining us for this episode of Managed Care Cast is Robert H. Hopkins Jr, MD, medical director at the National Foundation for ...
Attorneys General from several districts have come together in a lawsuit seeking damages from Walgreens for allegedly ...
This marketing decision from the FDA covers 2 nicotine strengths, 3 mg and 6 mg, and 10 flavors of the small tobacco-free ...
A topical treatment combining calcipotriol and 5-FU shows promise in reducing premalignant lesions and lowering skin cancer ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback